(Q30052502)

25 May 2017

author name string

Françoise Radat

1

1 reference

25 May 2017

Ivan Berlin

2

1 reference

25 May 2017

Odile Spreux-Varoquaux

3

1 reference

25 May 2017

Skander Elatki

4

1 reference

25 May 2017

Maurice Ferreri

5

1 reference

25 May 2017

Alain J. Puech

6

1 reference

25 May 2017

language of work or name

1 reference

June 1996

1 reference

25 May 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

Psychopharmacology

1 reference

25 May 2017

volume

127

1 reference

25 May 2017

issue

1-2

1 reference

25 May 2017

page(s)

370-376

1 reference

Comparison of the monoamine oxidase inhibiting properties of two reversible and selective monoamine oxidase-A inhibitors moclobemide and toloxatone, and assessment of their effect on psychometric performance in healthy subjects

25 May 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF02806017

Inhibition of platelet monoamine oxidase in depressed subjects treated with phenelzine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02806017

Inhibition of monoamine oxidase by moclobemide: effects on monoamine metabolism and secretion of anterior pituitary hormones and cortisol in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02806017

Pressor effect of oral tyramine during treatment with befloxatone, a new reversible monoamine oxidase-A inhibitor, in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02806017

A multiple-dose, controlled study of phenelzine in depression-anxiety states.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02806017

21 January 2018

Identifiers

DOI

10.1007/BF02806017

1 reference